Theriva Biologics, Inc. Quarterly Goodwill in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Theriva Biologics, Inc. quarterly Goodwill history and growth rate from Q4 2010 to Q2 2024.
  • Theriva Biologics, Inc. Goodwill for the quarter ending June 30, 2024 was $1.47M, a 73.9% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.47M -$4.16M -73.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $5.57M -$44K -0.78% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.7M +$175K +3.17% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $5.46M +$237K +4.54% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.62M -$597K -9.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $5.62M -$192K -3.31% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.53M +$5.53M Dec 31, 2022 10-K 2024-03-25
Q3 2022 $5.22M Sep 30, 2022 10-K 2023-03-30
Q2 2022 $6.22M Jun 30, 2022 10-K 2023-03-30
Q1 2022 $5.81M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-Q 2023-08-08
Q3 2011 $178K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $178K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $178K Dec 31, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.